{"id":"https://openalex.org/W2256976419","doi":"https://doi.org/10.1200/jco.1997.15.12.3496","title":"Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.","display_name":"Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.","alternate_titles":[],"publication_year":1997,"publication_date":"1997-12-01","ids":{"openalex":"https://openalex.org/W2256976419","doi":"https://doi.org/10.1200/jco.1997.15.12.3496","mag":"2256976419","pmid":"https://pubmed.ncbi.nlm.nih.gov/9396403"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1997.15.12.3496","doi":"https://doi.org/10.1200/jco.1997.15.12.3496","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1997.15.12.3496","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2256976419"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046775582","display_name":"Bob L\u00f6wenberg","orcid":"https://orcid.org/0000-0001-8982-5217","observed_orcids":["https://orcid.org/0000-0001-8982-5217"]},"institutions":[{"id":"https://openalex.org/I4210145518","display_name":"Hovon","ror":"https://ror.org/056kpdx27","country_code":"NL","type":"other","lineage":["https://openalex.org/I4210145518"]},{"id":"https://openalex.org/I4210148109","display_name":"Swiss Group For Clinical Cancer Research","ror":"https://ror.org/04rtrpb08","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4210148109"]},{"id":"https://openalex.org/I4405267285","display_name":"Daniel den Hoed Kliniek","ror":"https://ror.org/020rz5h24","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210149908","https://openalex.org/I4405267285"]}],"countries":["CH","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B L\u00f6wenberg","raw_affiliation_strings":["Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research: Daniel den Hoed Cancer Center Rotterdam, The Netherlands. lowenberg@haed.azr.nl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research: Daniel den Hoed Cancer Center Rotterdam, The Netherlands. lowenberg@haed.azr.nl","institution_ids":["https://openalex.org/I4210145518","https://openalex.org/I4210148109","https://openalex.org/I4405267285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111838826","display_name":"M. A. Boogaerts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M A Boogaerts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113778088","display_name":"Simon M. G. J. Daenen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S M Daenen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111910824","display_name":"G. E. G. Verhoef","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G E Verhoef","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043162057","display_name":"Anton Hagenbeek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Hagenbeek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050532707","display_name":"Edo Vellenga","orcid":"https://orcid.org/0000-0002-7741-8697","observed_orcids":["https://orcid.org/0000-0002-7741-8697"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E Vellenga","raw_affiliation_strings":["Guided Treatment in Optimal Selected Cancer Patients (GUTS)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guided Treatment in Optimal Selected Cancer Patients (GUTS)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108882243","display_name":"Gert Jan Ossenkoppele","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G J Ossenkoppele","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112976340","display_name":"Peter C. Huijgens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P C Huijgens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003455280","display_name":"Leo F. Verdonck","orcid":"https://orcid.org/0000-0003-3887-1007","observed_orcids":["https://orcid.org/0000-0003-3887-1007"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L F Verdonck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067992017","display_name":"Johannes Van der Lelie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J van der Lelie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109212306","display_name":"JJ Wielenga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J J Wielenga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034779401","display_name":"Harry C. Schouten","orcid":"https://orcid.org/0000-0002-2384-4797","observed_orcids":["https://orcid.org/0000-0002-2384-4797"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H C Schouten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000168086","display_name":"J Gm\u00fcr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Gm\u00fcr","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072582820","display_name":"Alois A. Gratwohl","orcid":"https://orcid.org/0000-0002-4821-1726","observed_orcids":["https://orcid.org/0000-0002-4821-1726"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Gratwohl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068100722","display_name":"U Hess","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"U Hess","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110137995","display_name":"Martin F. Fey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M F Fey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111877917","display_name":"Wim LJ van Putten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W L van Putten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.7762,"has_fulltext":false,"cited_by_count":131,"citation_normalized_percentile":{"value":0.89786457,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"15","issue":"12","first_page":"3496","last_page":"3506"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/hematopoietic-growth-factors","display_name":"hematopoietic growth factors","score":0.984000027179718},{"id":"https://openalex.org/keywords/hematopoietic-recovery","display_name":"hematopoietic recovery","score":0.7379999756813049},{"id":"https://openalex.org/keywords/neutrophil-recovery","display_name":"neutrophil recovery","score":0.8939999938011169},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.8790000081062317},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9660000205039978},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9440000057220459},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.40700000524520874},{"id":"https://openalex.org/keywords/young-and-middle-aged-adults","display_name":"young and middle-aged adults","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8930559158325195},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.643511950969696},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.5824052095413208},{"id":"https://openalex.org/C2777478134","wikidata":"https://www.wikidata.org/wiki/Q423660","display_name":"Granulocyte macrophage colony-stimulating factor","level":3,"score":0.5763731598854065},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5568065047264099},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5216439366340637},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4854639172554016},{"id":"https://openalex.org/C2779958370","wikidata":"https://www.wikidata.org/wiki/Q5711176","display_name":"Hematopoietic growth factor","level":4,"score":0.4677588641643524},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4522925913333893},{"id":"https://openalex.org/C2777983669","wikidata":"https://www.wikidata.org/wiki/Q223143","display_name":"Granulocyte","level":2,"score":0.44923123717308044},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4440962076187134},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3727934956550598},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.23104411363601685},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.1376451551914215},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001772","descriptor_name":"Blood Cell Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005069","descriptor_name":"Evaluation Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1200/jco.1997.15.12.3496","doi":"https://doi.org/10.1200/jco.1997.15.12.3496","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1997.15.12.3496","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:9396403","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9396403","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/05a49152-c31a-4393-a14a-902435a79400","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/05a49152-c31a-4393-a14a-902435a79400","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"L\u00f6wenberg, B, Boogaerts, MA, Daenen, SMGJ, Verhoef, GEG, Hagenbeek, A, Vellenga, E, Ossenkoppele, G, Huijgens, PC, Verdonck, LF, van der Lelie, J, Wielenga, JJ, Schouten, HC, Gmur, J, Gratwohl, A, Hess, U, Fey, MF & Putten, W 1997, 'Value of Different Modalities of Granulocyte-Macrophage Colony-Stimulating Factor Applied During or After Induction Therapy of Acute Myeloid Leukemia', Journal of Clinical Oncology, vol. 15, no. 12, pp. 3496-3506.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/c8032e18-17b5-440d-bf31-9a408cc453d4","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/c8032e18-17b5-440d-bf31-9a408cc453d4","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lowenberg, B, Boogaerts, MA, Daenen, SMGJ, Verhoef, GEG, Hagenbeek, A, Vellenga, E, Ossenkoppele, GJ, Huijgens, PC, Verdonck, LF, vanderLelie, J, Wielenga, JJ, Gmur, J, Gratwohl, A, Hess, U, Fey, MF & vanPutten, WLJ 1997, 'Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia', Journal of Clinical Oncology, vol. 15, no. 12, pp. 3496-3506.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/05a49152-c31a-4393-a14a-902435a79400","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/05a49152-c31a-4393-a14a-902435a79400","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Oncology, 15(12), 3496 - 3506. American Society of Clinical Oncology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/c8032e18-17b5-440d-bf31-9a408cc453d4","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/c8032e18-17b5-440d-bf31-9a408cc453d4","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Oncology, 15(12), 3496 - 3506. AMER SOC CLINICAL ONCOLOGY","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1002.5799","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1002.5799","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://hwmaint.jco.ascopubs.org/cgi/reprint/15/12/3496.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W64631301","https://openalex.org/W91972951","https://openalex.org/W107098111","https://openalex.org/W124601896","https://openalex.org/W207944929","https://openalex.org/W1519562949","https://openalex.org/W1585733692","https://openalex.org/W1586763410","https://openalex.org/W1971467770","https://openalex.org/W2011564019","https://openalex.org/W2013051826","https://openalex.org/W2092953524","https://openalex.org/W2147213204","https://openalex.org/W2150113701","https://openalex.org/W2169202300","https://openalex.org/W2204518675","https://openalex.org/W2318674152","https://openalex.org/W2339692928","https://openalex.org/W2409120826","https://openalex.org/W2410089930","https://openalex.org/W2410426763","https://openalex.org/W2410808924","https://openalex.org/W2411246781","https://openalex.org/W2412961637","https://openalex.org/W2413977968","https://openalex.org/W2438080541","https://openalex.org/W3112284273"],"related_works":["https://openalex.org/W2169202300","https://openalex.org/W1967377785","https://openalex.org/W2052595295","https://openalex.org/W2431965920","https://openalex.org/W2433853290","https://openalex.org/W2271497897","https://openalex.org/W2397533127","https://openalex.org/W2186888694","https://openalex.org/W3112284273"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,149],"hematopoietic":[2,52],"growth":[3],"factors":[4],"(HGFs)":[5],"introduced":[6],"into":[7],"induction":[8],"chemotherapy":[9],"(CT)":[10],"of":[11,18,69,81,161,165,233,236,240,248,250,274,280,287,292,303,313],"acute":[12],"myeloid":[13,298],"leukemia":[14],"(AML)":[15],"might":[16,35,50],"be":[17],"benefit":[19],"to":[20,44,65,101,271,283],"treatment":[21,193,311],"outcome":[22,312],"by":[23,289,300],"at":[24,173],"least":[25],"two":[26],"mechanisms.":[27],"HGFs":[28,46],"given":[29],"on":[30],"days":[31,216],"simultaneously":[32],"with":[33,106,318],"CT":[34,49,116,128,142,214,288,295,306],"sensitize":[36],"the":[37,67,192,251,272,284,290,301],"leukemic":[38],"cells":[39,282],"and":[40,54,90,126,169,178,186,202,238,261,315],"enhance":[41],"their":[42],"susceptibility":[43],"CT.":[45,277],"applied":[47,112],"after":[48,95,141,213,305],"hasten":[51],"recovery":[53,198,204,299],"reduce":[55],"morbidity":[56],"or":[57,85,92,139,296],"mortality.":[58],"MATERIALS":[59],"AND":[60],"METHODS:":[61],"We":[62],"set":[63],"out":[64],"evaluate":[66],"use":[68,232,273,291,302],"granulocyte-macrophage":[70],"colony-stimulating":[71],"factor":[72],"(GM-CSF;":[73],"5":[74],"microg/kg)":[75],"in":[76,97,180,208,266],"a":[77,157,246],"prospective":[78],"randomized":[79],"study":[80],"factorial":[82],"design":[83],"(yes":[84],"no":[86,93,133],"GM-CSF":[87,94,110,124,134,140,212,253,275,293,304],"during":[88,115,125,276,294],"CT,":[89],"yes":[91],"CT)":[96],"patients":[98,209,268],"aged":[99],"15":[100],"60":[102],"years":[103,175],"(mean,":[104],"42)":[105],"newly":[107,319],"diagnosed":[108,320],"AML.":[109,321],"was":[111,154],"as":[113,245],"follows:":[114],"only":[117,143],"(+/-,":[118],"n":[119,130,136,145],"=":[120,131,137,146],"64":[121],"assessable":[122],"patients),":[123],"following":[127],"(+/+,":[129],"66),":[132],"(-/-,":[135],"63),":[138],"(-/+,":[144],"60).":[147],"RESULTS:":[148],"complete":[150],"response":[151],"(CR)":[152],"rate":[153],"77%.":[155],"At":[156],"median":[158],"follow-up":[159],"time":[160],"42":[162],"months,":[163],"probabilities":[164],"overall":[166],"survival":[167,171],"(OS)":[168],"disease-free":[170],"(DFS)":[172],"3":[174],"were":[176,205,264],"38%":[177],"37%":[179],"all":[181],"patients.":[182],"CR":[183],"rates,":[184],"OS,":[185],"DFS":[187],"did":[188,242],"not":[189,243,308],"differ":[190],"between":[191],"groups":[194],"(intention-to-treat":[195],"analysis).":[196],"Neutrophil":[197],"(1.0":[199],"x":[200],"10(9)/L)":[201],"monocyte":[203],"significantly":[206,309],"faster":[207],"who":[210],"received":[211],"(26":[215],"v":[217],"30":[218],"days;":[219],"neutrophils,":[220],"P":[221,225],"<":[222,226],".001;":[223],"monocytes,":[224],".005).":[227],"Platelet":[228],"regeneration,":[229],"transfusion":[230],"requirements,":[231],"antibiotics,":[234],"frequency":[235],"infections,":[237],"duration":[239],"hospitalization":[241],"vary":[244],"function":[247],"any":[249],"therapeutic":[252],"modalities.":[254],"More":[255],"frequent":[256],"side":[257],"effects":[258,286],"(eg,":[259],"fever":[260],"fluid":[262],"retention)":[263],"noted":[265],"GM-CSF-treated":[267],"predominantly":[269],"related":[270],"CONCLUSION:":[278],"Priming":[279],"AML":[281],"cytotoxic":[285],"accelerating":[297],"does":[307],"improve":[310],"young":[314],"middle-aged":[316],"adults":[317]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2256976419","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
